These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31748840)

  • 41. A Practical Approach to Differentiate the Frontotemporal Tauopathy Subtypes.
    Forrest SL; Halliday GM; Sizemova A; van Roijen M; McGinley CV; Bright F; Kapur M; McGeachie AB; McCann H; Shepherd CE; Tan RH; Affleck AJ; Huang Y; Kril JJ
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1122-1126. PubMed ID: 32954432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
    Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes.
    Fodder K; Murthy M; Rizzu P; Toomey CE; Hasan R; Humphrey J; Raj T; Lunnon K; Mill J; Heutink P; Lashley T; Bettencourt C
    Acta Neuropathol; 2023 Jul; 146(1):77-95. PubMed ID: 37149835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrospinal fluid tau in frontotemporal lobar degeneration: clinical, neuroimaging, and prognostic correlates.
    Borroni B; Cerini C; Archetti S; Premi E; Cosseddu M; Ferrari M; Bellelli G; Gasparotti R; Caimi L; Di Luca M; Padovani A
    J Alzheimers Dis; 2011; 23(3):505-12. PubMed ID: 21098973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glial cells and adaptive immunity in frontotemporal dementia with tau pathology.
    Hartnell IJ; Blum D; Nicoll JAR; Dorothee G; Boche D
    Brain; 2021 Apr; 144(3):724-745. PubMed ID: 33527991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies.
    Campo MD; Pijnenburg YAL; Chen-Plotkin A; Irwin DJ; Grossman M; Twaalfhoven HAM; Hu WT; Meeter LH; van Swieten J; Vermunt L; Martens F; Heijboer AC; Teunissen CE
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
    Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
    Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence of corticofugal tau spreading in patients with frontotemporal dementia.
    Kim EJ; Hwang JL; Gaus SE; Nana AL; Deng J; Brown JA; Spina S; Lee MJ; Ramos EM; Grinberg LT; Kramer JH; Boxer AL; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
    Acta Neuropathol; 2020 Jan; 139(1):27-43. PubMed ID: 31542807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Progressive nonfluent aphasia].
    Murayama S; Saito Y
    Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erratum to: Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing.
    Schludi MH; May S; Grässer FA; Rentzsch K; Kremmer E; Küpper C; Klopstock T; ; ; Arzberger T; Edbauer D
    Acta Neuropathol; 2015 Oct; 130(4):557-8. PubMed ID: 26290407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late-onset behavioral variant of frontotemporal lobar degeneration versus Alzheimer's disease: Interest of cerebrospinal fluid biomarker ratios.
    Marelli C; Gutierrez LA; Menjot de Champfleur N; Charroud C; De Verbizier D; Touchon J; Douillet P; Berr C; Lehmann S; Gabelle A
    Alzheimers Dement (Amst); 2015 Sep; 1(3):371-9. PubMed ID: 27239517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
    Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
    Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
    Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frontotemporal lobar degeneration: recent progress in antemortem diagnosis.
    Bian H; Grossman M
    Acta Neuropathol; 2007 Jul; 114(1):23-9. PubMed ID: 17541785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correction to: Roles of Retinoic Acid Signaling in Shaping the Neuronal Architecture of the Developing Amphioxus Nervous System.
    Zieger E; Candiani S; Garbarino G; Croce JC; Schubert M
    Mol Neurobiol; 2018 Jun; 55(6):5230-5231. PubMed ID: 29429050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer's Disease and Frontotemporal Dementias.
    Constantinides VC; Paraskevas GP; Boufidou F; Bourbouli M; Pyrgelis ES; Stefanis L; Kapaki E
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolomic changes associated with frontotemporal lobar degeneration syndromes.
    Murley AG; Jones PS; Coyle Gilchrist I; Bowns L; Wiggins J; Tsvetanov KA; Rowe JB
    J Neurol; 2020 Aug; 267(8):2228-2238. PubMed ID: 32277260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.
    Hu WT; Chen-Plotkin A; Arnold SE; Grossman M; Clark CM; Shaw LM; McCluskey L; Elman L; Karlawish J; Hurtig HI; Siderowf A; Lee VM; Soares H; Trojanowski JQ
    Acta Neuropathol; 2010 Sep; 120(3):385-99. PubMed ID: 20652578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.
    Azoulay E; Bauer PR; Mariotte E; Russell L; Knoebl P; Martin-Loeches I; Pène F; Puxty K; Povoa P; Barratt-Due A; Garnacho-Montero J; Wendon J; Munshi L; Benoit D; von Bergwelt-Baildon M; Maggiorini M; Coppo P; Cataland S; Veyradier A; Van de Louw A;
    Intensive Care Med; 2020 Mar; 46(3):570-571. PubMed ID: 31965263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.
    Neumann M; Lee EB; Mackenzie IR
    Adv Exp Med Biol; 2021; 1281():201-217. PubMed ID: 33433877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.